Back to BAKER BROS. ADVISORS LP BAKER BROS. ADVISORS LP

CPRXCPRX
8 quarters

Position history for BAKER BROS. ADVISORS LPBAKER BROS. ADVISORS LP's holdings in CATALYST PHARMACEUTICALS INC

BAKER BROS. ADVISORS LP previously held 0 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $0 as of 2020-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$14.8M

Total Shares Change

-2.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%$3.42
0
2020-Q3
Decreased
474,400
-5.1%
$1.4M0.0%$3.21
0
2020-Q2
Decreased
500,000
-52.9%
$2.3M0.0%$4.56
0
2020-Q1
Decreased
1.1M
-20.9%
$4.1M0.0%$3.88
0
2019-Q4
Unchanged
1.3M
0.0%
$5M0.0%$3.67
0
2019-Q3
Decreased
1.3M
-47.6%
$7.1M0.0%$5.27
0
2019-Q2
Decreased
2.6M
-11.7%
$9.8M0.1%$3.84
0
2019-Q1
New
2.9M
-
$14.8M0.1%$5.10
39

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used